A 48-year-old woman with CKD stage 5 (eGFR 8 mL/min/1.73m²) and hemoglobin 7.2 g/dL is evaluated for anemia management. She has not yet started dialysis. Regarding erythropoiesis-stimulating agents (ESAs) and iron supplementation in CKD anemia, all of the following statements are correct EXCEPT:

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.